Current  	Current  	 JJ	B-NP
status  	status  	 NN	I-NP
of  	of  	 IN	I-NP
drug-eluting  	drug-eluting  	 JJ	I-NP
stents  	stents  	 NN	I-NP
and  	and  	 CC	O
drug-eluting  	drug-eluting  	 JJ	B-NP
balloons  	balloons  	 NNS	I-NP
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
stable  	stable  	 JJ	O
coronary  	coronary  	 JJ	B-NP
artery  	artery  	 NN	I-NP
disease--an  	disease--an  	 JJ	I-NP
expert  	expert  	 NN	I-NP
consensus  	consensus  	 NN	I-NP
document  	document  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
Association  	Association  	 NNP	O
for  	for  	 IN	O
Percutaneous  	Percutaneous  	 NNP	B-NP
Cardiovascular  	Cardiovascular  	 NNP	I-NP
Interventions  	Interventions  	 NNP	I-NP
and  	and  	 CC	O
Polish  	Polish  	 NNP	O
Cardiac  	Cardiac  	 NNP	O
Society  	Society  	 NNP	O
Despite  	Despite  	 IN	O
a  	a  	 DT	O
dramatic  	dramatic  	 JJ	O
reduction  	reduction  	 NN	O
in  	in  	 IN	O
restenosis  	restenosis  	 NN	B-NP
and  	and  	 CC	O
target  	target  	 NN	B-NP
vessel  	vessel  	 NN	I-NP
revascularisation  	revascularisation  	 NN	I-NP
rates  	rates  	 NNS	I-NP
by  	by  	 IN	O
drug  	drug  	 NN	B-NP
eluting  	eluting  	 NN	I-NP
stents  	stents  	 NNS	I-NP
( 	( 	 -LRB-	O
DES 	DES 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
conflicting  	conflicting  	 JJ	O
concerns  	concerns  	 NNS	O
have  	have  	 VBP	O
been  	been  	 VBN	O
raised  	raised  	 VBN	O
over  	over  	 IN	O
the  	the  	 DT	O
risk  	risk  	 NN	O
for  	for  	 IN	O
late  	late  	 JJ	O
DES  	DES  	 NNP	B-NP
thrombosis  	thrombosis  	 NN	O
when  	when  	 WRB	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
bare  	bare  	 JJ	O
metal  	metal  	 NN	B-NP
stents 	stents 	 NN	I-NP
.  	.  	 .	O
Certainly 	Certainly 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
heterogeneity  	heterogeneity  	 NN	B-NP
of  	of  	 IN	I-NP
DES  	DES  	 NNP	I-NP
results  	results  	 NNS	I-NP
from  	from  	 IN	O
the  	the  	 DT	O
introduction  	introduction  	 NN	B-NP
of  	of  	 IN	O
a  	a  	 DT	O
great  	great  	 JJ	O
variety  	variety  	 NN	O
of  	of  	 IN	O
new  	new  	 JJ	O
DES  	DES  	 NNP	B-NP
types  	types  	 NNS	O
with  	with  	 IN	O
diverse  	diverse  	 JJ	B-NP
efficacy  	efficacy  	 NN	I-NP
and  	and  	 CC	O
safety  	safety  	 NN	O
parameters 	parameters 	 NNS	O
.  	.  	 .	O
Furthermore 	Furthermore 	 RB	O
,  	,  	 ,	O
we  	we  	 PRP	O
observe  	observe  	 VBP	O
a  	a  	 DT	O
steady  	steady  	 JJ	O
increase  	increase  	 NN	O
in  	in  	 IN	O
DES  	DES  	 NNP	B-NP
availability  	availability  	 NN	O
without  	without  	 IN	O
parallel  	parallel  	 JJ	O
and  	and  	 CC	O
robust  	robust  	 JJ	O
data  	data  	 NNS	O
from  	from  	 IN	O
randomised  	randomised  	 JJ	B-NP
clinical  	clinical  	 JJ	I-NP
trials 	trials 	 NNS	I-NP
.  	.  	 .	O
Thus 	Thus 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
postulated  	postulated  	 JJ	O
class  	class  	 NN	B-NP
effect  	effect  	 NN	I-NP
of  	of  	 IN	I-NP
DES  	DES  	 NNP	I-NP
should  	should  	 MD	O
be  	be  	 VB	O
regarded  	regarded  	 VBN	O
as  	as  	 IN	O
non-obligatory 	non-obligatory 	 JJ	B-NP
.  	.  	 .	O
This  	This  	 DT	O
article  	article  	 NN	O
is  	is  	 VBZ	O
based  	based  	 VBN	O
on  	on  	 IN	O
110  	110  	 CD	O
randomised  	randomised  	 JJ	B-NP
DES  	DES  	 NNP	I-NP
trials  	trials  	 NNS	I-NP
performed  	performed  	 VBN	O
on  	on  	 IN	O
72  	72  	 CD	O
305  	305  	 CD	O
patients 	patients 	 NNS	O
.  	.  	 .	O
Current  	Current  	 JJ	B-NP
status  	status  	 NN	I-NP
of  	of  	 IN	I-NP
DES  	DES  	 NNP	I-NP
and  	and  	 CC	O
guidelines  	guidelines  	 NNS	O
for  	for  	 IN	O
DES  	DES  	 NNP	B-NP
implantation  	implantation  	 NN	I-NP
in  	in  	 IN	O
various  	various  	 JJ	O
clinical  	clinical  	 JJ	B-NP
scenarios  	scenarios  	 NNS	I-NP
were  	were  	 VBD	O
discussed 	discussed 	 VBN	O
.  	.  	 .	O
